Paper41239737
Liver-joint axis: Hepatitis B virus as a contributor to rheumatoid arthritis pathogenesis.
Wu H and 4 others. Virulence, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Liver-joint axis: Hepatitis B virus as a contributor to rheumatoid arthritis pathogenesis. Papers, record 41239737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41239737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liver-joint axis: Hepatitis B virus as a contributor to rheumatoid arthritis pathogenesis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Hepatitis B virus | Major topic |
| Liver | Major topic |
| Hepatitis B | Major topic |
| Joints | Major topic |
| Humans | |
| Animals | |
| Th17 Cells | |
| Signal Transduction |
Source PubMed
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35071501 | Hepatitis B virus reactivation in rheumatoid arthritis. | World J Clin Cases | 2022 | https://conductscience.org/library/papers/35071501 | PubMed |
| 2 | 8406351 | Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. | Hepatology | 1993 | https://conductscience.org/library/papers/8406351 | PubMed |
| 3 | 34733170 | Lactate Is a Metabolic Mediator That Shapes Immune Cell Fate and Function. | Front Physiol | 2021 | https://conductscience.org/library/papers/34733170 | PubMed |
| 4 | 36840482 | Risk of hepatitis B reactivation in HBsAg-/HBcAb+ patients after biologic or JAK inhibitor therapy for rheumatoid arthritis: A meta-analysis. | Immun Inflamm Dis | 2023 | https://conductscience.org/library/papers/36840482 | PubMed |
| 5 | 21225682 | Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia. | Arthritis Rheum | 2011 | https://conductscience.org/library/papers/21225682 | PubMed |
| 6 | 35240267 | Probiotics, prebiotics, and synbiotics to prevent or combat air pollution consequences: The gut-lung axis. | Environ Pollut | 2022 | https://conductscience.org/library/papers/35240267 | PubMed |
| 7 | 40680804 | Involvement of the tryptophan-kynurenine pathway in the pathogenesis of autoimmune diseases. | Exp Gerontol | 2025 | https://conductscience.org/library/papers/40680804 | PubMed |
| 8 | 39333690 | Upregulated PrPC by HBx enhances NF-κB signal via liquid-liquid phase separation to advance liver cancer. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/39333690 | PubMed |
| 9 | 28453967 | Therapeutic vaccination for chronic hepatitis B. | Curr Opin Virol | 2017 | https://conductscience.org/library/papers/28453967 | PubMed |
| 10 | 34870178 | Successful treatment of tofacitinib in a case with rheumatoid arthritis who experienced hepatitis B virus reactivation induced by tocilizumab and recovered from entecavir rescue therapy. | Arch Rheumatol | 2021 | https://conductscience.org/library/papers/34870178 | PubMed |
| 11 | 31865380 | An HBV-encoded miRNA activates innate immunity to restrict HBV replication. | J Mol Cell Biol | 2020 | https://conductscience.org/library/papers/31865380 | PubMed |
| 12 | 35417673 | The lung-brain axis: A new frontier in host-microbe interactions. | Immunity | 2022 | https://conductscience.org/library/papers/35417673 | PubMed |
| 13 | 31414920 | Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. | Expert Opin Ther Targets | 2019 | https://conductscience.org/library/papers/31414920 | PubMed |
| 14 | 35926270 | Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/35926270 | PubMed |
| 15 | 38282942 | Epidemiology and Risk Factors for Rheumatoid Arthritis Development. | Mediterr J Rheumatol | 2023 | https://conductscience.org/library/papers/38282942 | PubMed |
| 16 | 27013493 | Dysregulated bioenergetics: a key regulator of joint inflammation. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/27013493 | PubMed |
| 17 | 20439288 | Synovial tissue hypoxia and inflammation in vivo. | Ann Rheum Dis | 2010 | https://conductscience.org/library/papers/20439288 | PubMed |
| 18 | 33305467 | The roles of liver X receptor α in inflammation and inflammation-associated diseases. | J Cell Physiol | 2021 | https://conductscience.org/library/papers/33305467 | PubMed |
| 19 | 22687286 | Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22687286 | PubMed |
| 20 | 39107082 | Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis. | Ann Rheum Dis | 2024 | https://conductscience.org/library/papers/39107082 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41239737
GET https://conductscience.org/api/papers/v1/41239737/references?page=2